© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Fortrea Holdings Inc. (FTRE) stock declined over -0.29%, trading at $17.39 on NASDAQ, down from the previous close of $17.44. The stock opened at $17.54, fluctuating between $16.98 and $18.01 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jan 09, 2026 | 17.54 | 18.01 | 16.98 | 17.39 | 1.74M |
| Jan 08, 2026 | 18.25 | 18.25 | 17.20 | 17.44 | 1.19M |
| Jan 07, 2026 | 17.40 | 18.10 | 16.91 | 17.49 | 1.49M |
| Jan 06, 2026 | 18.12 | 18.67 | 17.36 | 17.54 | 2.83M |
| Jan 05, 2026 | 16.81 | 16.94 | 15.95 | 16.62 | 1.27M |
| Jan 02, 2026 | 17.26 | 17.27 | 16.20 | 16.81 | 1.18M |
| Dec 31, 2025 | 17.38 | 17.69 | 16.99 | 17.25 | 1.26M |
| Dec 30, 2025 | 17.23 | 17.48 | 17.08 | 17.38 | 688.87K |
| Dec 29, 2025 | 17.22 | 17.50 | 17.06 | 17.25 | 656.33K |
| Dec 26, 2025 | 18.04 | 18.04 | 17.29 | 17.40 | 831.53K |
| Dec 24, 2025 | 17.95 | 18.02 | 17.59 | 17.70 | 522.37K |
| Dec 23, 2025 | 17.45 | 17.97 | 17.11 | 17.91 | 821.33K |
| Dec 22, 2025 | 17.76 | 18.29 | 17.51 | 17.69 | 928.37K |
| Dec 19, 2025 | 16.61 | 18.05 | 16.61 | 17.74 | 3.06M |
| Dec 17, 2025 | 15.93 | 16.25 | 15.55 | 16.19 | 1.09M |
| Dec 16, 2025 | 15.77 | 16.31 | 15.63 | 15.99 | 930.85K |
| Dec 15, 2025 | 16.34 | 16.42 | 15.40 | 16.06 | 1.5M |
| Dec 12, 2025 | 16.05 | 16.33 | 15.43 | 15.72 | 1.27M |
| Dec 11, 2025 | 16.11 | 16.94 | 15.49 | 15.55 | 1.82M |
| Dec 10, 2025 | 14.39 | 15.50 | 14.02 | 15.14 | 1.42M |
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
| Employees | 15000 |
| Beta | 1.74 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | 0.097% |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Biotechnology |